ERG and prostate small cell carcinoma: Guo et al. [37] evaluated the TMPRSS2-ERG gene fusion in 12 small cell carcinomas of the prostate with small cell carcinomas of the bladder and lung as control, by fluorescent in situ hybridization (FISH), and found the aberration in about 67% of the cases and in none of the controls.